87475 CPT® code: payer coverage and prior authorization87475 appears in 8 coverage policies from Blue Cross & Blue Shield of Mississippi, Blue Cross Blue Shield of Massachusetts, Blue Cross NC, BlueCross BlueShield of South Carolina, Cigna, Premera Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Blue Cross & Blue Shield of Mississippi | Intravenous Antibiotic Therapy And Associated Diagnostic Testing For Lyme Disease | covered if criteria are met | payer document | |
| Blue Cross Blue Shield of Massachusetts | Identification of Microorganisms (555) | unproven / investigational | payer document | |
| Blue Cross Blue Shield of Massachusetts | Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease (171) | listed, no stance | payer document | |
| Blue Cross NC | Lyme Disease Testing AHS – G2143 | listed, no stance | Apr 1, 2026 | payer document |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 87003-87999) | Mar 1, 2024 | payer document |
| BlueCross BlueShield of South Carolina | Lyme Disease Testing (CAM 159) Code Number | listed, no stance | Apr 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Premera Blue Cross | Lyme Disease Testing | listed, no stance | Apr 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.